https://orcid.org/0000-0002-7335-1325
About the Authors
- Barbara L. Andersen
-
Contributed equally to this work with: Barbara L. Andersen, John Myers, Peter G. Shields, William E. Carson
Roles Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Psychology, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- John Myers
-
Contributed equally to this work with: Barbara L. Andersen, John Myers, Peter G. Shields, William E. Carson
Roles Data curation, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing
Affiliation Department of Biomedical Informatics and Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America
- Tessa Blevins
-
Roles Data curation, Visualization, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Psychology, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- Kylie R. Park
-
Roles Investigation, Resources, Validation, Visualization, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Psychology, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- Rachel M. Smith
-
Roles Data curation, Resources, Validation, Visualization, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Biomedical Informatics and Center for Biostatistics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America
- Sarah Reisinger
-
Roles Data curation, Investigation, Project administration, Supervision, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Internal Medicine, Division of Medical Oncology, College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- David P. Carbone
-
Roles Funding acquisition, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Internal Medicine, Division of Medical Oncology, College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- Carolyn J. Presley
-
Roles Funding acquisition, Writing – review & editing
¶‡ These authors also contributed equally to this work
Affiliation Department of Internal Medicine, Division of Medical Oncology, College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- Peter G. Shields
-
Contributed equally to this work with: Barbara L. Andersen, John Myers, Peter G. Shields, William E. Carson
Roles Funding acquisition, Supervision, Writing – review & editing
Affiliation Department of Internal Medicine, Division of Medical Oncology, College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
- William E. Carson
-
Contributed equally to this work with: Barbara L. Andersen, John Myers, Peter G. Shields, William E. Carson
Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: william.carson@osumc.edu
Affiliation Department of Surgery, Division of Surgical Oncology, College of Medicine, Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America
Competing Interests
BLA, JM, TB, KRP, RMS, SR, and WEC have no competing interests to declare. DPC reports personal fees from Abbvie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Celgene, Clovis, Daiichi Sankyo, Inc. (DSI), EMD Serono, Flame Biosciences, Foundation Medicine, G1Therapeutics/Intellisphere, GenePlus, Genentech/Roche, Glaxo-Smith-Kline, Gloria Biosciences, Gritstone, Guardant Health, Humana, Incyte, Inivata, Inovio, Janssen, Kyowa Kirin, Loxo Oncology, Merck, MSD, Nexus Oncology, Novartis, Oncocyte, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda Oncology, and Teva; and grants and personal fees from Bristol Myers-Squibb (BMS) outside the submitted work during the conduct of the study. This does not alter our adherence to PLOS ONE policies on sharing data and materials.